Reproducing human and cross-species drug toxicities using a Liver-Chip

…, D Simic, W Lam, M Singer, E Barale… - Science translational …, 2019 - science.org
Nonclinical rodent and nonrodent toxicity models used to support clinical trials of candidate
drugs may produce discordant results or fail to predict complications in humans, contributing …

The c-Met tyrosine kinase inhibitor JNJ-38877605 causes renal toxicity through species-specific insoluble metabolite formation

…, HH Bohets, HT Arkenau, A Lampo, E Barale… - Clinical Cancer …, 2015 - AACR
Purpose: The receptor tyrosine kinase c-Met plays an important role in tumorigenesis and is
a novel target for anticancer treatment. This phase I, first-in-human trial, explored safety, …

Immunohistochemistry for light microscopy in safety evaluation of therapeutic agents: an overview

R Burnett, Y Guichard, E Barale - Toxicology, 1997 - Elsevier
The history of immunohistochemistry started in 1941 when Coons identified pneumococci
using a direct fluorescent method. Then followed the indirect method, the addition of …

Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats

P Vinken, S Starckx, E Barale-Thomas… - Toxicologic …, 2012 - journals.sagepub.com
The kidney is one of the main targets of drug toxicity, and early detection of renal damage is
critical in preclinical drug development. A model of cisplatin-induced nephrotoxicity in male …

Recommendations for pathology peer review

D Morton, RS Sellers, E Barale-Thomas… - Toxicologic …, 2010 - journals.sagepub.com
Pathology peer review verifies and improves the accuracy and quality of pathology
diagnoses and interpretations. Pathology peer review is recommended when important risk …

Liver-Chip: Reproducing human and cross-species toxicities

…, J Nawroth, D Simic, W Lam, M Singer, E Barale… - BioRxiv, 2019 - biorxiv.org
Nonclinical rodent and non-rodent toxicity models used to support clinical trials of candidate
drugs may produce discordant results or fail to predict complications in humans contributing …

IMI—Bigpicture: a central repository for digital pathology

P Moulin, K Grünberg, E Barale-Thomas… - Toxicologic …, 2021 - journals.sagepub.com
To address the challenges posed by large-scale development, validation, and adoption of
artificial intelligence (AI) in pathology, we have constituted a consortium of academics, small …

The application, challenges, and advancement toward regulatory acceptance of digital toxicologic pathology: results of the 7th ESTP international expert workshop …

…, F Aeffner, E Barale-Thomas… - Toxicologic …, 2021 - journals.sagepub.com
With advancements in whole slide imaging technology and improved understanding of the
features of pathologist workstations required for digital slide evaluation, many institutions are …

Tamoxifen: 28-day oral toxicity study in the rat based on the Enhanced OECD Test Guideline 407 to detect endocrine effects

P Kennel, C Pallen, E Barale-Thomas, G Espuna… - Archives of …, 2003 - Springer
The main objective of this 28-day oral gavage toxicity study in the rat was to investigate which
of the current and/or additional parameters of the OECD Test Guideline 407 would reliably …

International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies

B Bolon, E Barale-Thomas, A Bradley… - Toxicologic …, 2010 - journals.sagepub.com
The International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a
common global framework for training future toxicologic pathologists who will support regulatory…